Results 191 to 200 of about 62,107 (256)

THU0198 Risk of Hospitalized Serious Infection in Spondylitis Ankylosing (AS) Patients Using Nbdmard or Anti-TNF

Annals of the Rheumatic Diseases, 2015
Background Nonbiologic Disease-modifying anti-rheumatic drugs (nbDMARDs) and anti-tumor necrosis factor (anti-TNFs) have been used in AS patients who do not respond adequately to non-steroidal anti-inflammatories (NSAIDs). However, concerns exist regarding the risk of serious infections 1 .
C.S. Moura, E. Rahme, W.P. Maksymowych, M. Abrahamowicz, L. Bessette, S. Bernatsky   +5 more
openaire   +1 more source

Skeletal indicators of reactive arthritis: A case study comparison to other skeletal conditions, such as rheumatoid arthritis, ankylosing spondylitis, ankylosing sero-negative SpA, and DISH

International Journal of Paleopathology, 2015
In this case study we report a unique modern case of severe reactive arthritis (Reiter's Syndrome) observed on an elderly Cypriot female from the St. Nicholas cemetery in Limassol, Cyprus and the successful differential diagnosis of the condition. The individual exhibited lesions specific to fusion of the thoracic and lumbar spinal column, primarily ...
William D, Cawley, Robert R, Paine
openaire   +2 more sources

Hereditary and Exogenous Etiological Factors in Ankylosing Spondylitis: Ankylosing Spondylitis in Two Sets of Monozygotic Twins

Acta Rheumatologica Scandinavica, 1960
SummaryTwo sets of monozygotic twins with concordant and discordant ankylosing spondylitis are reported. The 9 reported sets of monozygotic twins with ankylosing spondylitis are reviewed. Concordance in 6 seems to confirm the existence of hereditary factors, whereas discordance in 3, including unmistakable discordance in 1, shows that exogenous factors
openaire   +2 more sources

FRACTURE-DISLOCATIONS OF THE ANKYLOSED THORACIC SPINE IN RHEUMATOID SPONDYLITIS

The Journal of Trauma: Injury, Infection, and Critical Care, 1967
S T, Hansen, T K, Taylor, J C, Honet, F R, Lewis   +3 more
openaire   +2 more sources

Human medicines European public assessment report (EPAR): Erelzi, etanercept, Arthritis, Psoriatic,Psoriasis,Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid,Spondylitis, Ankylosing, Date of authorisation: 23/06/2017, Revision: 4, Status: Authorised

Case Medical Research, 2019
openaire   +2 more sources

Human medicines European public assessment report (EPAR): Lifmior, etanercept, Arthritis, Psoriatic,Spondylitis, Ankylosing,Psoriasis, Date of authorisation: 13/02/2017, Revision: 7, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Arthritis, Psoriatic,Psoriasis,Spondylitis, Ankylosing, Date of authorisation: 14/01/2015, Revision: 13, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Arthritis, Psoriatic,Psoriasis,Spondylitis, Ankylosing, Date of authorisation: 14/01/2015, Revision: 11, Status: Authorised

Case Medical Research, 2018
openaire   +1 more source

Human medicines European public assessment report (EPAR): Lifmior, etanercept, Arthritis, Psoriatic,Spondylitis, Ankylosing,Psoriasis, Date of authorisation: 13/02/2017, Revision: 6, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source